Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PGMN3.SA
BuyEmpreendimentos Pague Menos S.A. · Healthcare · Brazil · $490M · Avg Vol: $3M/d
75
StockRankGet insider-trade alerts
Q
61
V
79
M
30
P/E (TTM)
6.9x
ROE
10.6%
D/E
1.0x
Dividend %
7.4%
COMPANY DESCRIPTION
Empreendimentos Pague Menos S.A. engages in the retail sale of medicines, perfumeries, and personal hygiene and beauty products in Brazil.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.2B | 11.2B | 12.6B | 14.9B | 17.5% | 15.8B | 15.6B | 17.5B | 8.4% |
| EPS (BRL) | 0.56 | 0.01 | 0.22 | 0.40 | -10.5% | 0.51 | 0.47 | 0.59 | 21.5% |
| Shares | 464.1M | 552.9M | 582.0M | 665.0M | +43.3% | 718.9M | — | — | — |
| Debt | 3.8B | 3.8B | 3.5B | 3.7B | -1.1% | 3.5B | — | — | — |
| Equity | 2.3B | 2.7B | 2.7B | 3.1B | 9.7% | — | — | — | — |
| Op CF | 146.5M | 491.6M | 384.5M | 200.4M | 11.0% | 346.0M | — | — | — |
| Inv CF | -670.3M | -314.1M | -91.7M | -254.7M | — | — | — | — | — |
| Fin CF | 33.5M | 97.3M | -582.1M | 90.9M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+0.3%
SMA 50SMA 200
Close
$0.6551
RSI (14)
53.3
52W High
$1.46
From 52W High
0.4%
SCORE BREAKDOWN
Quality
61
ROIC
10.7%75.6
ROE
10.6%73.5
GP/Assets
50.9%87.3
Op. Margin
6.8%58.3
FCF/Assets
-0.6%43.9
Piotroski
376.5
Int. Cover
1.3x41.9
D/E Ratio
1.02x14.4
Current Ratio
1.78x34.2
Value
79
P/E (TTM)
6.9x94.7
EV/EBITDA
6.2x87.9
P/FCF
—N/A
P/B
0.7x91.9
P/S
0.2x98.6
Div Yield
7.4%96.8
Momentum
30
52W High %
45%17.7
RS 6M
-44%19.3
SMA 50/200
0.68x7.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+36%47.3
Q Growth
42%70.8
FUNDAMENTALS
Market Cap
$490M
P/E (Forward)
5.1x
Gross Margin
32.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PGMN3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PGMN3.SA | Empreendimentos Pague Menos S.A.(you) | $490M | 75 | Buy |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $62M | 95 | Strong Buy |
| RADL3.SA | Raia Drogasil S.A. | $6.7B | 64 | Hold |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 88 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $636M | 59 | Hold |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 97 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 98 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $93M | 87 | Strong Buy |
Peer medians: ROE 10.5% · P/E 13.3x · Gross margin 30.3%